Brief: Black Diamond Therapeutics Announces CEO Transition
18/09/2023 12:03
Sept 18 (Reuters) - Black Diamond Therapeutics Inc
BDTX.O :
* BLACK DIAMOND THERAPEUTICS ANNOUNCES CEO TRANSITION
* BLACK DIAMOND THERAPEUTICS INC - MARK VELLECA APPOINTED
CEO
* BLACK DIAMOND THERAPEUTICS INC: VELLECA SUCCEEDS DAVID M.
EPSTEIN
Source text for Eikon: ID:nGNX83f5dt
Further company coverage: BDTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Black Diamond Therapeutics
See all newsBlack Diamond Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Black Diamond Therapeutics Q2 net loss narrows year over year
Black Diamond Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Black Diamond Therapeutics Q4 net loss narrows, full-year profit turns positive
U.S. STOCKS ON THE MOVE-Spirit AeroSystems, Boeing, Roblox